Gurpreet Singh1, Pavneet Singh Kohli2, Dinesh Bagaria2. 1. Department of Surgery, Post Graduate Institute of Medical Education & Research (P.G.I.M.E.R.), Chandigarh, India. Electronic address: gsinghpgi@gmail.com. 2. Department of Surgery, Post Graduate Institute of Medical Education & Research (P.G.I.M.E.R.), Chandigarh, India.
Abstract
BACKGROUND: We present a new approach for BCS which we have named as the Lateral Oncoplastic Breast Surgery (LOBS) approach. METHODS: Patients with biopsy proven breast cancer or phyllodes tumors in the outer quadrants of the breast were selected. The patients were operated in the lateral position using the principles of a Level 1 oncoplastic technique. RESULTS: 106 patients (93 breast cancer; 13 phyllodes tumor) were operated using this technique. For patients with breast cancer the mean tumor size was 2.7 cms. 3 patients had a positive margin. The mean tumor size for phyllodes tumors was 6.7 cms. Surgical site infections (15 patients), marginal skin necrosis (2 patients) and superficial NAC necrosis (1 patient) were observed. Although the mean follow up was only 355.8 days there were no early detected recurrences. CONCLUSIONS: LOBS is a new approach for BCS which offers distinct advantages. The short term results, both oncological and aesthetic, are encouraging. SUMMARY: A new approach for performing oncoplastic breast conserving surgery (BCS) is described and the short term results of our first 106 cases are presented. Advantages of this approach over conventional techniques are reviewed.
BACKGROUND: We present a new approach for BCS which we have named as the Lateral Oncoplastic Breast Surgery (LOBS) approach. METHODS:Patients with biopsy proven breast cancer or phyllodes tumors in the outer quadrants of the breast were selected. The patients were operated in the lateral position using the principles of a Level 1 oncoplastic technique. RESULTS: 106 patients (93 breast cancer; 13 phyllodestumor) were operated using this technique. For patients with breast cancer the mean tumor size was 2.7 cms. 3 patients had a positive margin. The mean tumor size for phyllodes tumors was 6.7 cms. Surgical site infections (15 patients), marginal skin necrosis (2 patients) and superficial NACnecrosis (1 patient) were observed. Although the mean follow up was only 355.8 days there were no early detected recurrences. CONCLUSIONS: LOBS is a new approach for BCS which offers distinct advantages. The short term results, both oncological and aesthetic, are encouraging. SUMMARY: A new approach for performing oncoplastic breast conserving surgery (BCS) is described and the short term results of our first 106 cases are presented. Advantages of this approach over conventional techniques are reviewed.